Nikon Corporation
Diversified hardware conglomerate: premium consumer camera/lens sales (Z-mount mirrorless), high-ASP capital equipment (litho steppers/scanners, metrology), recurring healthcare/microscope and components revenue, plus a loss-making digital-manufacturing (metal 3D printing) unit. Mix of one-time hardware sales and some service/consumables.
Earnings, margins, COGS & capex
FY2026 (ended March 2026) was a record loss year: revenue JPY 677.1B (-5.3%), operating LOSS JPY 112.4B (vs JPY 2.4B profit FY2025) and net loss JPY 86.0B attributable to owners (vs JPY 6.1B profit FY2025). The loss was driven almost entirely by a JPY 90.6B goodwill/intangible impairment on the Nikon SLM Solutions metal-3D-printing acquisition in Digital Manufacturing (goodwill JPY 60.6B + intangibles JPY 26.2B written down), plus a downturn in semiconductor/FPD lithography unit sales and softer Healthcare. Notably, the camera (Imaging) business stayed clearly profitable. Management guides FY2027 (ending March 2027) to revenue JPY 740B and a return to JPY 10B operating profit / JPY 10B net profit.
Income statement — where each revenue dollar goes
% of revenueOf every $1 of revenue, ~60¢ is cost of goods and ~40¢ operating expense, and the remainder is an operating loss.
Revenue trend
Margins
collapsed from +0.3% FY2025 on impairment
record loss
down from ~14% FY2025 and ~18.6% FY2023
modest recovery, still depressed
COGS structure
Cost base is optics/glass manufacturing, image sensors (largely sourced from Sony Semiconductor), precision mechatronics and capital-equipment assembly; FX (yen) and tariffs pressured FY2026 margins. Group gross margin ~40% historically; Imaging margin compression reflects promotional pricing and mix.
Capex
Capital-goods and optics manufacturing require ongoing plant/R&D capex; R&D spend being optimized as part of restructuring. No large disclosed capacity build in the loss year.
Latest earnings
Big miss vs original guidance — the company originally guided FY2026 to a modest net profit, cut the outlook to an ~JPY 85B loss after the Q3 SLM impairment, and actual came in at a JPY 86.0B loss
FY2027: revenue JPY 740B, operating profit JPY 10B, net profit JPY 10B; targets a recovery path after the reset
- Camera unit shipments FY2026
- ~910k (approx; entry-level mirrorless solid)
- Interchangeable lens shipments
- ~1.3M units (approx)
- SLM/Digital Mfg impairment
- JPY 90.6B (non-cash; goodwill JPY 60.6B + intangibles JPY 26.2B)
- Dividend
- FY2026 40 yen (cut from 50); FY2027 guided 20 yen; yield ~0.9-1.8%; uncovered by FY2026 earnings
Growth drivers
- Z-mount mirrorless system (bodies + high-margin lenses) and the RED Digital Cinema acquisition (2024) pushing Nikon into professional cine cameras
- Semiconductor/FPD lithography recovery — legacy i-line/ArF steppers and next-gen nanoimprint lithography (NIL) as a differentiated bet vs EUV
- Healthcare/microscopy (bioscience, retinal/ophthalmic imaging) as a steadier, higher-margin base
- Components (encoders, optical parts, EUV-related optical components) tied to the semi cycle
- Cost/restructuring self-help: non-recurrence of one-time costs, idle-asset sales, R&D optimization
Bull & bear
An asset-heavy optics franchise where a one-time, non-cash write-down masks a profitable core camera business and optionality in semis and healthcare — a self-help + cycle-recovery re-rating.
- The JPY 90.6B loss driver is a non-cash impairment; underlying cash generation and the JPY 16.7B-profit Imaging unit are intact
- Stock trades ~1.3x book (~JPY 748B cap vs ~JPY 588B equity) with modest net debt — downside partly cushioned by tangible assets and the brand
- FY2027 guidance already flips back to operating and net profit (JPY 10B each); no repeat impairment is a big YoY tailwind
- Z-mount lens ecosystem plus RED cinema gives a higher-margin, stickier razor-and-blades mix in Imaging
- Optionality: nanoimprint lithography, healthcare/microscopy, and a semi-capex upcycle are all call options not priced into a loss-year multiple
- Restructuring, idle-asset sales and R&D optimization provide a management-controllable margin path
A structurally low-return conglomerate with a shrinking core camera TAM, an also-ran lithography position behind ASML, and a track record of value-destroying M&A — cheap for a reason.
- The SLM write-off signals weak capital allocation; the market discounts future M&A and diversification bets
- Even excluding the impairment, FY2026 was an operating loss and FY2027 guides to just ~1.35% operating margin — thin, fragile profitability
- Camera unit volumes (~910k) are a fraction of the historic peak; smartphones keep compressing the addressable market
- Precision Equipment lacks EUV and is squeezed between ASML at the leading edge and Canon in the legacy/NIL niche
- Dividend was cut twice and remains uncovered — reserves/debt fund it, a negative signal
- Multiple cyclical + FX + tariff exposures make earnings hard to underwrite; value-trap risk at ~1.3x book with low ROE
What it is worth
Relative multiples + asset value; loss year distorts earnings-based metrics
Value trap — persistent sub-cost-of-capital returns, further Digital Manufacturing losses, more dividend cuts and camera-TAM erosion compress it toward book (JPY 500-600B).
Range-bound near current levels (~JPY 650-800B, ~1.1-1.4x book). Cheap on a sum-of-parts/asset basis but low ROE and thin margins cap re-rating until a durable earnings recovery is proven.
Re-rating toward a mid-cycle multiple as FY2027+ returns to profit with no repeat impairment, Imaging cash flow holds, and semi/healthcare recover — value toward JPY 900B-1.1T on normalized ~JPY 40-50B group operating profit.
~JPY 748B market cap (~$4.6B) is ~1.1x FY2026 sales, ~1.2x EV/sales (EV ~JPY 810B incl. ~JPY 62B net debt), and ~1.3x book (equity ~JPY 588B) — above, not at, stated book. FY2026 EPS negative (~JPY -262), so no meaningful trailing P/E; on FY2027 guided net profit of JPY 10B the forward P/E is a rich ~75x, underscoring that the case rests on normalized (not FY2027) earnings power and asset value, not near-term profit. Sum-of-parts: a profitable Imaging franchise (~JPY 16-17B OP) plus optionality in litho/healthcare, less a still-fixing Digital Manufacturing drag.
SWOT
Strengths
- Premium optics/imaging brand with a loyal professional and enthusiast base; Z-mount system now maturing with a strong lens lineup
- Rare full-stack precision-optics capability — one of only three lithography makers globally (with ASML and Canon) and a leader in metrology/microscopy
- Camera business remained profitable (JPY 16.7B OP) even in a record group-loss year — a real cash engine
- Asset-heavy balance sheet: equity ~JPY 588B, total assets ~JPY 1.08T, modest net debt (~JPY 62B)
- RED Digital Cinema acquisition opens the high-end cinema/video market
Weaknesses
- FY2026 record loss exposed poor M&A discipline — the SLM Solutions (metal 3D printing) deal was almost entirely written off (JPY 90.6B)
- Precision Equipment lithography is a distant follower to ASML (no EUV) and shares the older-node niche with Canon
- Consumer camera TAM is structurally smaller than the pre-smartphone peak; growth is share-of-a-shrunk-pie
- Dividend cut twice (50 to 40 yen FY2026, guided 20 yen FY2027) and still not covered by FY2026 earnings/FCF
- Diversification has diluted returns; group operating margin structurally thin even ex-impairment
Opportunities
- Nanoimprint lithography (NIL) as a lower-cost patterning alternative for select semiconductor/advanced-packaging applications
- Professional video/cinema expansion via RED; hybrid photo/video creators
- Healthcare/bioscience imaging and industrial metrology as higher-margin, less-cyclical revenue
- Restructuring/self-help upside — cost-out, idle-asset monetization, exiting or fixing Digital Manufacturing
- Valuation re-rating if FY2027 returns to profit with no repeat impairment
Threats
- Smartphone computational photography continues to erode the entry/mid camera market
- ASML dominance and the EUV transition marginalize Nikon's litho relevance over time
- Semiconductor and FPD capex cyclicality swings Precision Equipment and Components
- Yen volatility and US/global tariffs (flagged as FY2026 headwinds)
- Intense camera competition from Sony and Canon on sensors, AF and video, plus rising Chinese competition in metal 3D printing
Moats, dependencies & bottlenecks
Moats
Moderate-strong Long but eroding at the leading edge One of three lithography makers globally (with ASML and Canon) and a top microscopy/metrology name; deep glass and mechatronics IP. But no EUV, so the moat is in legacy nodes, metrology and NIL, not the frontier.
Mount ecosystem and pro loyalty create switching costs; offset by a shrinking camera TAM and strong Sony/Canon competition.
Bioscience/industrial imaging and optical components give recurring, less-cyclical demand and specialized customer relationships.
Dependencies
Nikon sources CMOS sensors largely from Sony Semiconductor — a direct camera competitor is also a key input supplier.
Precision Equipment and Components revenue swings with fab/panel investment; FY2026 downturn cut litho unit sales.
Yen and tariff moves materially hit FY2026 revenue and margins.
Premium camera/lens sales are cyclical and competing with smartphones.
Already impaired JPY 90.6B; further losses or divestiture costs possible amid rising Chinese metal-AM competition.
Advantages
- Vertically integrated optics/glass and precision-mechatronics manufacturing
- Dual profit engines: profitable Imaging plus capital-equipment optionality
- Asset-heavy balance sheet (equity ~JPY 588B, total assets ~JPY 1.08T) with modest leverage
- Differentiated bets (nanoimprint litho, RED cinema, bioscience imaging)
- Restructuring levers within management control (cost-out, asset sales)
Weaknesses
- Poor recent M&A/capital-allocation record (SLM write-off)
- Twice-cut, uncovered dividend and negative FY2026 FCF
- Structurally sub-scale vs ASML (litho) and Sony (sensors/imaging)
- Multiple cyclical + FX exposures create earnings volatility
- Consumer camera secular headwind from smartphones
Bottlenecks
- Metal-3D-printing (Digital Manufacturing) unit is loss-making and post-impairment; drag until fixed, sold or wound down
- No EUV lithography capability caps upside in the largest, fastest-growing semi-equipment segment
- Camera TAM ceiling limits Imaging to share gains, not market growth
- Thin group margins leave little buffer against FX/cyclical shocks
- Dividend coverage — cash returns constrained until profitability recovers
Top signals & trends
Top signals
Bearish (backward-looking) · Large but non-cash and largely one-time; kitchen-sink year.
Signals management sees a bottom; execution risk remains.
Core cash engine intact despite group loss.
Cheap on a sum-of-parts/asset basis but above stated book; low ROE could make it a value trap.
Reduced twice and still unsupported by FY2026 earnings/FCF; funded from reserves/debt.
Trends
Compresses entry/mid camera demand; pushes Nikon upmarket to pro/enthusiast.
Z-mount video + RED cinema align Nikon with growing video demand.
Nikon absent from EUV; relevance concentrates in legacy nodes, metrology and NIL.
Positive (optional) · NIL and packaging optics could open new litho demand pockets.
Weak yen aids export translation but input/tariff costs and volatility hurt.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
Primary CMOS image-sensor supplier for many Nikon cameras.
Optical glass/materials supplier to the precision-optics industry.
Advanced chips for camera/equipment processors and imaging pipelines.
Contract manufacturers (Thailand/Japan optics plants) Camera/lens assembly and optical component fabrication.
Consumers & professional photographers/videographers Camera and interchangeable-lens buyers; core Imaging demand.
Buyers of lithography steppers/scanners, metrology and optical components.
research labs & life-science institutions Microscopy, bioscience imaging and healthcare products.
Metrology, encoders and (formerly) metal additive customers.
Closest overall analog — cameras/lenses, semiconductor & FPD lithography (incl. its own nanoimprint push), and medical/optics. Direct rival in both Imaging and Precision Equipment.
Dominates full-frame mirrorless (Alpha) and is the leading CMOS image-sensor supplier — competitor and key supplier to Nikon simultaneously.
Lithography leader (DUV + EUV monopoly). Structurally marginalizes Nikon's litho at the leading edge.
Competes in mirrorless (X/GFX) and has large healthcare/imaging and materials businesses overlapping Nikon's diversification.
Additive-manufacturing peer to Nikon's Digital Manufacturing (SLM) unit; illustrates the tough economics of the segment Nikon just wrote down.
Industrial 3D-printing competitor to Nikon SLM in metal/advanced additive.
Scientific/microscopy and life-science imaging competitor overlapping Nikon Healthcare/microscopy.
Leica microscopy and life-science tools compete with Nikon's bioscience microscope line.